Equity Research Specialty Chemicals

Should You Buy ASP Isotopes Inc. Stock in 2026?

By CirclFi Research Team · · Updated · 2/13 models active

According to the CirclFi Deep Alpha Valuation Engine, ASP Isotopes Inc. (ASPI) carries a solid Quality of Company rating of 6.0/10. Trading at $3.16, our multi-model framework evaluates whether the company's financial profile offers a favorable risk-reward setup.

The short answer: 0 of 2 CirclFi valuation models project upside for ASP Isotopes Inc. (ASPI) at $3.16 — the model consensus leans bearish, with a Quality Score of 6.0/10 and Value-Trap risk of 21/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 2 of 2 models suggest overvaluation — majority bearish
  • Quality Score: 6.0/10 — Moderate — mixed signals
  • Value Trap Risk: 21/100 — Minimal — healthy fundamentals
  • Fair Value Range: $0.40 – $0.58 (46% spread)

Bullish Models

0 / 2

Bearish Models

2 / 2

Quality Score

6.0 /10

Moderate — mixed signals

Value Trap Risk

21 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

2 /13
Active Models

Avg. confidence: 52%

What Is the Investment Case for ASP Isotopes Inc. (ASPI) in 2026?

What Is the Bull Case vs the Bear Case for ASP Isotopes Inc. (ASPI)?

Bull case versus bear case for ASP Isotopes Inc. (ASPI) at $3.16, derived from 2 active CirclFi valuation models on 2026-09-15.
Bull case Bear case — $0.40 target (-87.5%)
No active model projects meaningful upside for ASPI at $3.16. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. According to the CirclFi Deep Alpha Valuation Engine, the Dynamic NAV model sees the stock as overvalued with a fair value of $0.40 (-87.5%), suggesting that the market price embeds overly optimistic growth assumptions.
Industry headwind: labor market tightness represents a meaningful risk for ASP Isotopes Inc. and its Specialty Chemicals peers.

How Does ASPI Compare to Its Specialty Chemicals Peers?

FF FutureFuel Corp.
6.1
PRM Perimeter Solutions,
6.0
LWLG Lightwave Logic, Inc
6.1
BLGO BioLargo, Inc.
5.9
CC The Chemours Company
6.1
RLEA Rubber Leaf Inc.
5.8
YMAT J-Star Holding Co.,
3.1
NTIC Northern Technologie
8.2

Valuation data pages: FF · PRM · LWLG · BLGO · CC · RLEA · YMAT · NTIC · OEC · ODC · RPM

See full Specialty Chemicals rankings →

Which Other Stocks Score Like ASPI on Quality?

Closest companies to ASPI’s Quality of Company score of 6.0/10, across all industries.

Why Do CirclFi’s 2 Models Disagree on ASPI?

Spread

46%

Fair Value Range

$0.40 – $0.58

A tight 46% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

ML-RIV

$0.58 (-81.7%)

Most Bearish

Dynamic NAV

$0.40 (-87.5%)

What Are the Biggest Risks of Buying ASPI Stock?

Bearish Consensus

2/2 models suggest overvaluation.

Macro/Sector Risk

Specialty Chemicals headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View ASPI Data Page →

So Is ASP Isotopes Inc. (ASPI) Worth Buying in 2026?

Our valuation engine sends a clear cautionary signal on ASP Isotopes Inc. at $3.16. 2/2 models flag overvaluation, median fair value sits at $0.49 (-84.6%), and the risk-reward profile appears unfavorable. Quality at 6.0/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. ASP Isotopes Inc.'s future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About ASPI Stock?

Should I buy ASPI stock right now?

Based on CirclFi's multi-model analysis, 0 of 2 models see upside for ASPI at $3.16. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in ASP Isotopes Inc.?

Key risks include: limited model coverage (2/13 active), reducing analytical confidence; general market and sector-specific risks affecting Specialty Chemicals companies. Always diversify and consult a financial advisor.

How does ASPI compare to its competitors?

Among Specialty Chemicals peers, ASPI holds a Quality Score of 6.0/10. Comparable companies include FF (QOC 6.1), PRM (QOC 6.0), LWLG (QOC 6.1). The relative ranking helps investors identify whether ASPI offers better fundamental quality than alternatives in the same sector.

Is ASPI a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. ASPI's Quality Score of 6.0/10 suggests moderate fundamentals — not a clear long-term hold without further research into growth catalysts. Check our full data page for all 13 model estimates.

What price should I buy ASPI at?

CirclFi does not provide target buy prices or price alerts. However, our 2 active models produce fair value estimates ranging from $0.40 to $0.58. At $3.16, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for ASPI.

View ASPI Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →